# Cunjiankang.com

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cunjiankang-com

- Industry: Healthcare IT
- Headquarters: Wuhan, China
- Website: www.cunjk.com
- Latest round: Series B (Mar 10, 2023)
- Investors on record: 1

## About

Based in Wuhan, China, and founded in 2013, Cunjiankang.com operates as a health testing brand that focuses on providing digital application services and solutions for the pharmaceutical and health industries. There are more than 200 employees in the company and the core team members worked at Tencent. The company has passed Wuhan High-tech Enterprise, Big Data Enterprise, Gazelle Enterprise and National Network Information Security Level III Certification.  Some enterprises, such as Dashen Lin medicine group Limited, China Resources Sanjiu Medical&Pharmaceutical, Laobaixing Pharmacy Chain Joint Stock Company, and Cspc Holdings Company Limited, have cooperated with the company.

Based on the CRM system for pharmacies, the company provides pharmacies with integrated online and offline membership operations, enabling them to provide better services to their members. The main products are DTP Patient Management System and Cunjiankang Supply and Zero Pass System. The DTP patient management system can help DTP pharmacies and dual access pharmacies create SOPs for managing and serving patients with serious chronic illnesses. The company's products have covered to 30 provinces nationwide, serving more than 1100 enterprises in the pharmaceutical retail industry, with nearly 400 million members.

## Funding rounds

- Series B, Mar 10, 2023 — QF Capital

## Investors

- QF Capital (https://capitalatlas.ai/funds/qf-capital) — Series B